Answer
Gloves, goggles and protective clothing are recommended when handling the Eisai Ltd eribulin mesylate 0.44 mg/ml solution for injection product; only personnel appropriately trained in handling cytotoxic agents should prepare and administer it, and pregnant staff should not handle it.
Sources for this answer
- Eribulin Eisai 0.44 mg/ml solution for injectionEisai Ltd · emc · SmPC §6.6 Special precautions for disposal and other handling · Version 26Document updated
Sources checked